Cure of neuroendocrine carcinoma by peptide receptor radionuclide therapy.
Zöphel
Klaus
K
Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Dresden, Germany.
Strumpf
Annette
A
Wunderlich
Gerd
G
Oehme
Liane
L
Eisenhofer
Graeme
G
Kotzerke
Joerg
J
D001859:Bone Neoplasms / Q000532:radiotherapy* / Q000556:secondary*; D018278:Carcinoma, Neuroendocrine / Q000532:radiotherapy* / Q000556:secondary*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000532:radiotherapy* / Q000556:secondary*; D008875:Middle Aged; D015282:Octreotide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D016896:Treatment Outcome
D019275:Radiopharmaceuticals; C496730:90Y-octreotide, DOTA-Tyr(3)-; D015282:Octreotide